Nuvus.io Presale

Status

Active

Description

Big data exchange for medical cannabis.

Starting date

February 8th, 2018

Ending date

March 18th, 2018

Website

View Website

Whitepaper

View Whitepaper

Links
Features

Nuvus Blockchain is building global exchange platform for big data and supply chain verification ecosystem using distributive ledger technologies through public blockchain and private permissioned blockchain for the Medical and Recreational Cannabis.

Currently, supply chain data is non-transparent and is controlled by centralized organizations and authorities, subject to industry manipulation and slowing the adoption of life saving treatments and research.

Nuvus Blockchain technology, if globally adopted, will add billions of data points to the supply chain, benefiting medicinal research and proper diagnosis in patients. By bringing decentralized, immutable blockchain technologies with billions of live, verified data points to the cannabis industry, we expect to add significant value and transparency to the Industries supply chain.

Parent company of Nuvus Blockchain is Nuvus Corp. Team has a combined 25 years experience in the cannabis industry building out the most sophisticated and award winning products in the industry. They are responsible in developing industry’s first cannabis personal test kits, Controlled Environment Agriculture automation technology for the purest cannabis plants, industry’s first and only use of big data analytics and AI for small and large grow facilities.

Whitelist
Yes
Token Sale Hard Cap
$ 70 000 000
Token Sale Soft Cap
$ 35 000 000
Presale Start Date
February 1st, 2018
Presale End Date
March 18th, 2018
Token Symbol
GET
Token Type
Ethereum
Token Distribution
15% Founders & Team, 2.5% Advisors, 2.5% Early investors, 20% Reserved Controlled Fund, 40% Pre-Sale, 20% Crowdsale
Initial Token Price
0.80 USD
KYC
Yes
Accepts
BTC ETH USD
Core Team

Sam Talari
CEO

John Verghese
COO

Terry N. Gardner
VP Engineering

Deirdre Fernandes
VP Operations

Bobban Subhadra PH.D.
Chief Technology Officer

Olga Krynina
Global Marketing VP

Alan Mathon
Researcher